Publications 2025
- Yamada H, Abe S, Charvat H, Ando T, Maeda M, Murakami K, Oka S, Maekita T, Sugimoto M, Furuta T, Kaise M, Yamamichi N, Takamaru H, Sasaki A, Oda I, Nanjo S, Suzuki N, Sugiyama T, Kodama M, Mizukami K, Ito M, Kotachi T, Shimazu T, Yamamoto S and Ushijima T. Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study. Gut, 74: 1410-1418, 2025. PMID: 40240063
- Liu YY, Ohashi Y and Ushijima T. How chronic inflammation fuels carcinogenesis as an environmental epimutagen. Discov Oncol, 16: 1150, 2025. PMID: 40533660
- Hattori N, Takamatsu H, Iida N, Asano N, Yamashita S, Oba GM, Kimura K, Yoshida A, Kobayashi E, Nakayama R, Matsumoto M, Nakamura M, Kawai A and Ushijima T. Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value. Front Oncol, 15: 1419877, 2025. PMID: 40371227
- Sato F, Oku T, Nishigaki Y, Suzuki M, Sakai H, Takeshima H and Kato Y. Microfibril-Associated Protein 5 Contributes to the Elastic Fiber Abnormalities in Aged Skin. Biol Pharm Bull, 48: 450-456, 2025. PMID: 40268468
- Endo Y, Sugino RP, Takenobu H, Mukae K, Okada R, Shinno Y, Haruta M, Satoh S, Akter J, Hattori N, Nakazawa A, Ushijima T, Nakagawara A, Ohira M, Nio M and Kamijo T. Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization. BMC Cancer, 25: 1759, 2025. PMID: 41225513
- Sekita T, Asano N, Kubo T, Totsuka H, Mitani S, Hattori N, Yoshida A, Kobayashi E, Komiyama M, Ushijima T, Nakayama R, Nakamura M, Kawai A and Ichikawa H. Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma. Neoplasia, 59: 101074, 2025. PMID: 39591761
MORE
